Status:

COMPLETED

Feasibility of Internet-delivered CBT for Adolescents With Depression

Lead Sponsor:

Karolinska Institutet

Collaborating Sponsors:

Region Stockholm

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

13-17 years

Phase:

NA

Brief Summary

Prior to a properly powered randomized controlled study, evaluating efficacy and cost-effectiveness of ICBT, we will conduct a pilot study to investigate if the trial design is feasible, if therapist-...

Detailed Description

A single-blind parallel-group pilot randomised controlled feasibility trial with the overall aim to develop two internet-delivered cognitive behaviour therapy interventions, therapist-guided and self-...

Eligibility Criteria

Inclusion

  • Primary diagnosis of mild to moderate MDD according to the Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
  • Willing to be randomized to either of the three treatment arms.
  • Basic proficiency in Swedish, both adolescent and participating care-giver
  • Regular access to a desktop or laptop computer connected to the internet, as well as a mobile phone to receive sms (one of each is enough per family).
  • Stable medication with antidepressants, central stimulants and neuroleptics at least 6 weeks prior to inclusion.
  • A minimum of one caregiver that is able to co-participate in the treatment.

Exclusion

  • Immediate risk to self or others, requiring urgent medical attention, such as suicidality, or repeated self-injurious behaviour.
  • Other severe psychiatric disorders requiring other actions at first hand (e.g. diagnosis of organic brain disorder, intellectual disability, psychosis, bipolar disorder, eating disorder, or alcohol/substance dependence;
  • Current social problems requiring other actions at first hand (e.g. bullying in school, abuse and/or neglect in the family; high and prolonged absence from school).
  • Previous CBT for MDD within the last 12 months prior to assessment, for a minimum of 3 sessions other than psychoeducation with a qualified therapist within the 12 months prior to assessment.
  • Current use of benzodiazepines.
  • An ongoing psychological treatment for any other psychiatric disorder.

Key Trial Info

Start Date :

October 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 21 2020

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT04117789

Start Date

October 14 2019

End Date

October 21 2020

Last Update

October 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Child and Adolescent Psychiatry Research Center

Stockholm, Sweden, 11330